Integrity of the permeability barrier regulates epidermal Langerhans cell density

British Journal of Dermatology

Volumn 134, Issue 4, 1996, Pages 630-638

  Proksch, E ^a   Brasch, J ^a   Sterry, W ^b  

^a UNIVERSITY OF KIEL   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONE; CD3 ANTIGEN; CD4 ANTIGEN; DODECYL SULFATE SODIUM; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1;

ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; LANGERHANS CELL; NORMAL HUMAN; PRIORITY JOURNAL; SKIN PERMEABILITY;

EID: 0029925924     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1996.tb06961.x     Document Type: Article

References (34)

1. Smack PD, Korge BP, James WD, Keratin and keratinization. J Am Acad Dermatol 1994; 30: 85-102.
2. Jiang C-K, Magnaldo T, Ohtsuki M et al. Epidermal growth factor and transforming growth factor α specifically induce the activation- and hyperprolifieration-association keratins 6 and 16. Proc Natl Acad Sci USA 1993; 90: 6785-90.
3. Elias PM. Skin lipids. Adv Lipid Res 1991; 24: 1-262.
4. Proksch E, Elias PM, Feingold KR. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in normal epidermis: modulation of enzyme content and activation state by barrier requirements. J Clin Invest 1990; 85: 874-82.
5. Proksch E, Feingold KR, Mao-Qiang M, Elias PM. Barrier function regulates epidermal DNA synthesis. J Clin Invest 1991; 87: 1668-73.
6. Proksch E, Holleran WM, Menon GK et al. Barrier function regulates epidermal lipid and DNA synthesis. Br J Dermatol 1993; 128: 473-82.
7. Menon GK, Elias PM, Feingold KR. Integrity of the permeability barrier is crucial for maintenance of the epidermal calcium gradient. Br J Dermatol 1994; 130: 139-47.
8. Wood LC, Jackson SM, Elias PM et al. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 1992; 90: 482-7.
9. Rowden G. The Langerhans cell. CRC Crit Rev Immunol 1981; 95-180.
10. Sterry W, Künne W, Weber-Matthiesen K et al. Cell trafficking in positive and negative patch-test reactions: demonstration of a sterotypic migration pathway. J Invest Dermatol 1991; 96: 459-62.
11. Rosén K, Kontell M, Mobacken H, Rosdahl J. Epidermal Langerhans cells in chronic eczematous dermatitis of the palms treated with PUVA and UVB. Acta Derm Venereol (Stockh) 1989; 69: 200-5.
12. Spruit D, Malten KE. The regeneration rate of the water vapor loss of heavily damaged skin. Dermatologica 1966; 132: 115-25.
13. Horton JJ, Allen MM, MacDonald MA. An assessment of Langerhans cell quantification in tissue sections. J Am Acad Dermatol 1984; 11: 591-3.
14. Breathnach SM. Origin, cell linkage, oncogeny, tissue distribution and kinetics of Langerhans cells. In: Epidermal Langerhans Cells. (Schuler G, ed), Boca Raton: CRC Press, 1991; 33-45.
15. Stingl G, Wolff K. Cellular interactions in the skin: the epidermis as an immune organ. Triangle 1987; 26: 139-53.
16. Uno H, Hanifin JM. Langerhans cells in acute and chronic epidermal lesions of atopic dermatitis, observed by L-dopa, histofluorescence, glycol methacrylate thin section, and electron microscopy. J Invest Dermatol 1980; 75: 52-60.
17. Muhlbauer JE, Bhan AK, Harrist TJ et al. Papular polymorphic light eruption: an immunoperoxidase study using monoclonal antibodies. Br J Dermatol 1983; 108: 153-62.
18. Entestan L, Koaman T, Hovmark A, Asbrink E. An immunohistochemical staining of epidermal Langerhans' cells in tinea cruris. Acta Derm Venereol (Stockh) 1985; 65: 240-72.
19. Brasch J, Martens H, Sterry W. Langerhans cell accumulation in chronic tinea pedis and pityriasis versicolor. Clin Exp Dermatol 1993; 18: 329-32.
20. Nickoloff BJ, Naidu Y. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J Am Acad Dermatol 1994; 30: 535-46.
21. Bergstresser PR, Cruz PD Jr. The influence of ultraviolet radiation and other physical and chemical agents on epidermal Langerhans cells. In: Epidermal Langerhans Cells. (Schuler G, ed), Boca Raton: CRC Press 1991; 254-71.
22. Aberer W, Romani N, Elbe A, Stingl G. Effects of physicochemical agents on murine epidermal Langerhans cells and THY-1-positive dendritic epidermic cells. J Immunol 1986; 136: 1210-16.
23. Williams NA. Effects on murine epidermal Langerhans cells of drugs known to cause recrudescent herpes simplex virus infection in a mouse model. J Invest Dermatol 1991; 97: 933-7.
24. Brasch J, Burgard W, Sterry W. Common pathogenetic pathways in allergic and irritant contact dermatitis. J Invest Dermatol 1992; 98: 166-70.
25. Streilein JW, Lonsberry LW, Bergstresser PR. Depletion of epidermal Langerhans cells and Ia immunogenicity from tape-stripped mouse skin. J Exp Med 1982; 155: 863-71.
26. Lessard RJ, Wolff K, Winkelmann RK. Induced 'shedding' of the epidermal Langerhans cells. Nature 1966; 212: 628-30.
27. Braun-Falco O, Christophers E, Kurban A. Abnormales Verhalten der epidermalen Regeneration bei Patienten mit Psoriasis vulgaris. Arch Klin Exp Dermatol 1967; 229: 276-84.
28. Fisher LB, Maibach HJ. The effect of occlusive and semipermeable dressings on the mitotic activity of normal and wounded human epidermis. Br J Dermatol 1972; 86: 593-600.
29. Kreipe H, Heidebrecht HJ, Hansen S et al. A new proliferation-associated nuclear antigen detectable in paraffin-embedded tissues by the monoclonal antibody Ki-Sl. Am J Pathol 1993; 142: 1-9.
30. Potter CS, Allen TD. A model implicating the Langerhans cells in keratinocyte proliferation control. Differentiation 1976; 5: 43-7.
31. Emanuel RJ. Requisition of keratinocyte proliferation. J Invest Dermatol 1993; 101: 105.
32. Heufler C, Topar G, Koch F et al. Cytokine gene expression in murine epidermal cell suspensions: interleukin-1β (Il-1β) and macrophage inflammatory protein-1α (MIP-1α) are selectively expressed in Langerhans cells but are differentially regulated in culture. J Exp Med 1992; 176: 1221-6.
33. Parkinson EK, Graham GJ, Daubersies P et al. Hemopoietic stem cell inhibitor (SCI/MIP-1α) also inhibits clonogenic epidermal keratinocyte proliferation. J Invest Dermatol 1993; 101: 113-17.
34. Tazi A, Bouchonnet F, Grandsaigne M et al. Evidence that granulocyte macrophage-colony-stimulaung factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers. J Clin Invest 1993; 91: 566-76.